Emerging therapies for endometriosis

Reflections
Emerging therapies for endometriosis

VOLUME 115, ISSUE 2, P317-318

Author:

Hugh S. Taylor, M.D.

Abstract:

Reflections on "Relugolix, an oral GnRH receptor antagonist, reduces endometriosis-associated pain in a dose-response manner: a randomized, double-blind, placebo-controlled study" by Osuga et al.

Read the full text here.